Page last updated: 2024-08-25

almagate and oligonucleotides

almagate has been researched along with oligonucleotides in 19 studies

Research

Studies (19)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's16 (84.21)29.6817
2010's3 (15.79)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adamis, AP; Cunningham, ET; Feinsod, M; Gragoudas, ES; Guyer, DR1
Nimjee, SM; Rusconi, CP; Sullenger, BA1
Fine, SL; Kirkpatrick, P; Martin, DF1
Coster, DJ; van Wijngaarden, P; Williams, KA1
Schachat, AP1
Morrow, T1
Blaise, P; Foidart, JM; Rakic, JM1
Keating, GM; Siddiqui, MA1
Hansen, MH; Mortensen, KK; Sjølie, AK1
Haamann, PH; la Cour, M; Larsen, M; Lund-Andersen, H; Sander, B; Villumsen, JE1
Adamis, AP; Aiello, LP; Altaweel, M; Bressler, NM; Cunningham, ET; D'Amico, DJ; Goldbaum, M; Guyer, DR; Katz, B; Patel, M; Schwartz, SD1
Bozza, M; Dilone, E; Galazka, M; Scypinski, S; Sheardy, RD1
Wacheck, V1
Winkler, J1
Goto, R; Inomata, E; Miyakawa, S; Nakamura, Y; Takami, T; Yamaura, J1
Castanotto, D; Stein, CA1

Reviews

6 review(s) available for almagate and oligonucleotides

ArticleYear
Aptamers: an emerging class of therapeutics.
    Annual review of medicine, 2005, Volume: 56

    Topics: Animals; Anti-Infective Agents; Antidotes; Aptamers, Nucleotide; Bacterial Proteins; Clinical Trials, Phase III as Topic; DNA-Binding Proteins; Drug Delivery Systems; Drug Design; Drug Evaluation, Preclinical; Drugs, Investigational; Gene Library; HIV Infections; Humans; Oligonucleotides; Transcription Factors; Viral Proteins

2005
Inhibitors of ocular neovascularization: promises and potential problems.
    JAMA, 2005, Mar-23, Volume: 293, Issue:12

    Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Diabetic Retinopathy; Humans; Injections; Macular Degeneration; Oligonucleotides; Ranibizumab; Vascular Endothelial Growth Factor A

2005
Pegaptanib: in exudative age-related macular degeneration.
    Drugs, 2005, Volume: 65, Issue:11

    Topics: Animals; Aptamers, Nucleotide; Humans; Injections; Macular Degeneration; Oligonucleotides; Randomized Controlled Trials as Topic; Visual Acuity; Vitreous Body

2005
[Oligonucleotide therapeutics - an emerging novel class of compounds].
    Wiener medizinische Wochenschrift (1946), 2006, Volume: 156, Issue:17-18

    Topics: Aptamers, Nucleotide; Drug Delivery Systems; Gene Expression; Humans; Oligodeoxyribonucleotides; Oligonucleotides; Oligonucleotides, Antisense; RNA, Small Interfering; Structure-Activity Relationship; Thionucleotides

2006
Therapeutic oligonucleotides with polyethylene glycol modifications.
    Future medicinal chemistry, 2015, Volume: 7, Issue:13

    Topics: Animals; Aptamers, Nucleotide; Drug Discovery; Humans; Oligonucleotides; Oligonucleotides, Antisense; Polyethylene Glycols; RNA, Small Interfering

2015
FDA-Approved Oligonucleotide Therapies in 2017.
    Molecular therapy : the journal of the American Society of Gene Therapy, 2017, 05-03, Volume: 25, Issue:5

    Topics: Aptamers, Nucleotide; Clinical Trials as Topic; Cytomegalovirus Retinitis; Drug Approval; Hepatic Veno-Occlusive Disease; Humans; Hypercholesterolemia; Macular Degeneration; Morpholinos; Muscular Atrophy, Spinal; Muscular Dystrophy, Duchenne; Oligonucleotides; Oligonucleotides, Antisense; Polydeoxyribonucleotides; Thionucleotides

2017

Trials

3 trial(s) available for almagate and oligonucleotides

ArticleYear
Pegaptanib for neovascular age-related macular degeneration.
    The New England journal of medicine, 2004, Dec-30, Volume: 351, Issue:27

    Topics: Aged; Aged, 80 and over; Aptamers, Nucleotide; Choroidal Neovascularization; Double-Blind Method; Female; Humans; Injections; Macular Degeneration; Male; Middle Aged; Oligonucleotides; Photochemotherapy; Prospective Studies; Radiography; Vascular Endothelial Growth Factor A; Visual Acuity; Vitreous Body

2004
[Treatment of neovascular age-related macular degeneration with intravitreal vascular endothelial growth factor inhibitor--secondary publication].
    Ugeskrift for laeger, 2005, Aug-29, Volume: 167, Issue:35

    Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Aptamers, Nucleotide; Choroidal Neovascularization; Female; Fluorescein Angiography; Humans; Injections; Macular Degeneration; Male; Middle Aged; Oligonucleotides; Photochemotherapy; Treatment Outcome; Vascular Endothelial Growth Factors; Visual Acuity; Vitreous Body

2005
A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema.
    Ophthalmology, 2005, Volume: 112, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Aptamers, Nucleotide; Diabetic Retinopathy; Double-Blind Method; Female; Humans; Injections; Macular Edema; Male; Middle Aged; Oligonucleotides; Safety; Tomography, Optical Coherence; Treatment Outcome; Vascular Endothelial Growth Factor A; Visual Acuity; Vitreous Body

2005

Other Studies

10 other study(ies) available for almagate and oligonucleotides

ArticleYear
New drugs and dosage forms.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2005, Feb-01, Volume: 62, Issue:3

    Topics: Adenine Nucleotides; Adolescent; Adult; Aptamers, Nucleotide; Arabinonucleosides; Azabicyclo Compounds; Child; Child, Preschool; Clofarabine; Contraindications; Diethylcarbamazine; Dosage Forms; Fibroblast Growth Factor 7; Fibroblast Growth Factors; Humans; Iloprost; Infant; Meglumine; Middle Aged; Oligonucleotides; omega-Conotoxins; Organometallic Compounds; Piperazines; Saquinavir; Trypan Blue

2005
Pegaptanib sodium.
    Nature reviews. Drug discovery, 2005, Volume: 4, Issue:3

    Topics: Aptamers, Nucleotide; Double-Blind Method; Humans; Macular Degeneration; Oligonucleotides; Randomized Controlled Trials as Topic; Treatment Outcome; Vascular Endothelial Growth Factor A

2005
New treatments for age-related macular degeneration.
    Ophthalmology, 2005, Volume: 112, Issue:4

    Topics: Aptamers, Nucleotide; Dietary Supplements; Humans; Laser Coagulation; Macular Degeneration; Oligonucleotides; Ophthalmologic Surgical Procedures; Photochemotherapy; Pregnadienediols

2005
Aptamers: slowing progression of AMD.
    Managed care (Langhorne, Pa.), 2005, Volume: 14, Issue:3

    Topics: Age Factors; Aptamers, Nucleotide; Disease Progression; Humans; Macular Degeneration; Oligonucleotides; United States; Vision, Ocular

2005
Pegaptanib and age-related macular degeneration.
    The New England journal of medicine, 2005, Apr-21, Volume: 352, Issue:16

    Topics: Aptamers, Nucleotide; Choroidal Neovascularization; Dose-Response Relationship, Drug; Humans; Injections; Macular Degeneration; Oligonucleotides; Vitreous Body

2005
New drug treats form of age-related macular degeneration. Macugen inhibits progression of wet AMD and also may restore some vision.
    Health news (Waltham, Mass.), 2005, Volume: 11, Issue:5

    Topics: Aged; Angiogenesis Inhibitors; Aptamers, Nucleotide; Humans; Macular Degeneration; Oligonucleotides

2005
Pegaptanib sodium (Macugen) for macular degeneration.
    The Medical letter on drugs and therapeutics, 2005, Jul-04, Volume: 47, Issue:1212

    Topics: Aptamers, Nucleotide; Humans; Injections; Macular Degeneration; Oligonucleotides; Vision Disorders; Vitreous Body

2005
[Antiangiogenesis therapy of age-related macular degeneration].
    Ugeskrift for laeger, 2005, Aug-29, Volume: 167, Issue:35

    Topics: Aged; Angiogenesis Inhibitors; Aptamers, Nucleotide; Humans; Injections; Macular Degeneration; Oligonucleotides; Vascular Endothelial Growth Factors; Vitreous Body

2005
Characterization of the secondary structure and stability of an RNA aptamer that binds vascular endothelial growth factor.
    Biochemistry, 2006, Jun-20, Volume: 45, Issue:24

    Topics: Aptamers, Nucleotide; Base Sequence; Calorimetry, Differential Scanning; Circular Dichroism; Dose-Response Relationship, Drug; Humans; Nucleic Acid Conformation; Nucleic Acid Denaturation; Oligonucleotides; Polyethylene Glycols; Protein Binding; RNA; Sodium Chloride; Temperature; Thermodynamics; Vascular Endothelial Growth Factor A

2006
De novo sequencing of highly modified therapeutic oligonucleotides by hydrophobic tag sequencing coupled with LC-MS.
    Journal of mass spectrometry : JMS, 2017, Volume: 52, Issue:2

    Topics: Aptamers, Nucleotide; Base Sequence; Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; Hydrophobic and Hydrophilic Interactions; Molecular Weight; Oligonucleotides; Spectrometry, Mass, Electrospray Ionization; Vascular Endothelial Growth Factor A

2017